Table 4.
Descriptive characteristics of included studies.
| Author | Male Sex (%) |
Age (Years) mean ± SD |
Indication for Anticoagulation (%) |
Severity of ACHD (%) | Thrombotic Events n (%) |
Bleeding Events n (%) | CHA2ADSVA2Sc ≥ 2 (%) | HAS-BLED ≤ 2 (%) | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AA | PTP | STP | Simple | Moderate | Complex | |||||||
| Yang et al. [28] | 55% | 47.0 ± 15.0 | 90.8 | 3.2 | 6.0 | 14.9 | 45.1 | 40.0 | 6 (1.1) | 7 (1.3) | 46.4 | 95.0 |
| Pujol et al. [29] | 48% | 48.4 ± 15.4 | 66.8 * | 5.6 * | 42.9 * | 32.1 | 23.7 | 44.2 | 2 (0.7) | 9 (3.1) | 49.3 | 87.5 |
| Georgekutty et al. [30] | 47% | 33.5 ± 8.0 | 57.0 | 9.5 | 33.3 | - | - | 100 | 1 (4.76) | 0 | 42.9 | 100 |
Abbreviations: AA: atrial arrhythmias; PTP: primary thromboprophylaxis; STP: secondary thromboprophylaxis. * Many patients had more than one indication for anticoagulation treatment (e.g., atrial arrhythmias and stroke/transient ischemic attack).